Dr. Zausner Skarbnik is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
125 Queens Rd
suite 600
Charlotte, NC 28204- Is this information wrong?
Education & Training
City of Hope Comprehensive Cancer CenterAdult Hematopoietic Stem Cell Transplantation, 2013 - 2014
Temple University HospitalFellowship, Hematology and Medical Oncology, 2010 - 2013
Icahn School of Medicine at Mount Sinai/Morningside/WestResidency, Internal Medicine, 2007 - 2010
Universidade de Sao Paulo Faculty of MedicineClass of 2003
Certifications & Licensure
CA State Medical License 2013 - Present
NC State Medical License Active through 2024
DC State Medical License 2018 - 2020
NJ State Medical License 2014 - 2019
PA State Medical License 2010 - 2014- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Check Point Inhibition After Autologous Stem Cell Transplantation in Patients at High Risk of Post Transplant Recurrence Start of enrollment: 2016 Jun 07
Publications & Presentations
PubMed
- An indirect comparison of acalabrutinib with and without obinutuzumab versus zanubrutinib in treatment-naive CLL.John N Allan, Dan James, Helen Bridge, Miguel Miranda, Alan Sm Yong, Fady Fam, Jack Roos, Vikram Shetty Dr, Adam S Kittai, Alan P Skarbnik, Matthew S Davids> ;Blood Advances. 2024 Apr 10
- 1 citationsActivity of venetoclax in patients with relapsed or refractory chronic lymphocytic leukaemia: analysis of the VENICE-1 multicentre, open-label, single-arm, phase 3b tr...Arnon P Kater, Önder Arslan, Fatih Demirkan, Yair Herishanu, Burhan Ferhanoglu, Marcos Gonzalez Diaz, Brian Leber, Marco Montillo, Panayiotis Panayiotidis, Davide Ross...> ;The Lancet. Oncology. 2024 Apr 1
- Hypertension Treatment in Patients Receiving Ibrutinib: A Multicenter Retrospective Study.Laura Samples, Jenna M Voutsinas MPH, Bita Fakhri, Sirin Khajavian, Stephen E Spurgeon, Deborah M Stephens, Alan P Skarbnik, Anthony R Mato, Catherine Broome, Ajay K G...> ;Blood Advances. 2024 Feb 2
- Join now to see all
Abstracts/Posters
- An Innovative Telemedicine Platform to Provide Expert Access to Patients with Chronic Lymphocytic Leukemia (CLL)Alan Skarbnik, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Efficacy of Therapies Following Venetoclax Discontinuation in CLL: Focus on B-Cell Receptor Signal Transduction Inhibitors and Cellular TherapiesAlan Skarbnik, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Toxicities and Outcomes of Acalabrutinib-Treated Patients with Chronic Lymphocytic Leukemia: A Retrospective Analysis of Real World PatientsAlan Skarbnik, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Join now to see all
Lectures
- Phase I/II Study of Escalating Doses of Thalidomide in Conjunction with Bortezomib and High Dose Melphalan As a Conditioning Regimen for Autologous Stem Cell Transplan...2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Elevated IL-1Ra Levels in the Stem Cell Product Is Associated with the Development of Engraftment Syndrome Following Autologous Stem Cell Transplantation for the Treat...2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Safety and Efficacy Data for Combined Checkpoint Inhibition with Ipilimumab (Ipi) and Nivolumab (Nivo) As Consolidation Following Autologous Stem Cell Transplantation ...2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Professional Memberships
- Member
- Member
- American Society of Blood and Marrow TransplantationMember
Other Languages
- Portuguese, Spanish
Hospital Affiliations
Novant Health Presbyterian Medical CenterCharlotte, North Carolina
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
